Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.

@article{Serruys2002FluvastatinFP,
  title={Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.},
  author={Patrick W Serruys and Pim J. de Feyter and Carlos Marcelino D{\'i}az Macaya and Norbert Kokott and Jacques Puel and Matthias Vrolix and Angelo Branzi and Marcelo Chiara Bertolami and Graham D.F. Jackson and Bradley H. Strauss and Bernhard Meier},
  journal={JAMA},
  year={2002},
  volume={287 24},
  pages={
          3215-22
        }
}
CONTEXT Percutaneous coronary intervention (PCI) is associated with excellent short-term improvements in ischemic symptoms, yet only three fifths of PCI patients at 5 years and one third of patients at 10 years remain free of major adverse cardiac events (MACE). OBJECTIVE To determine whether treatment with fluvastatin reduces MACE in patients who have undergone PCI. DESIGN AND SETTING Randomized, double-blind, placebo-controlled trial conducted at 77 referral centers in Europe, Canada, and… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 241 CITATIONS, ESTIMATED 46% COVERAGE

514 Citations

02040'02'05'09'13'17
Citations per Year
Semantic Scholar estimates that this publication has 514 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
SHOWING 1-10 OF 20 REFERENCES

Similar Papers

Loading similar papers…